Back to Search Start Over

Efficacy and safety of MPC-7869 (R-flurbiprofen), a selective ab42-lowering agent, in mild Alzheimer's disease (AD): Results of a 12-month Phase 2 trial and 1-year follow-on study

Authors :
Black, S
Wilcock, G
Haworth, J
Hendrix, S
Zavitz, K
Christensen, D
Binger, M
Bass, S
Laughlin, M
Swabb, E
Source :
NEUROLOGY. 66(5)
Publication Year :
2006

Details

ISSN :
00283878
Volume :
66
Issue :
5
Database :
OpenAIRE
Journal :
NEUROLOGY
Accession number :
edsair.dedup.wf.001..c19be33441ce7ec3cdb9841fd366f0bc

Tools

Authors Abstract Subjects Details